FISC Norfolk Contracting Department Philadelphia intends to solicit on a sole source basis as a commercial items acquisition effort using Simplified Acquisition Procedures per FAR part 13.5 for GMP tetravalent Dengue Vaccine in proprietary adjuant (vexfactin 5-10 g per plasmid for 4 plasmids with Vical Inc of San Diego, CA. The manufacturing of this product will be IAW accepted FDA standards. The required delivery date for this acquisition is extremely short in order to maintain testing schedules. A firm fixed price commercial items contract is the expected result of this acquisition effort. The NAICS code for this acquisition is 325414. The RFP will be issued on or around the week of 5 May 08, and will be posted to the Navy Electronic Commerce Office @ WWW.NECO.Navy.Mil upon its release. The proposed contract action is for supplies or services for which the Government intends to solicit and negotiate with only the source listed above, under the authority of the Clinger Cohen act, other DNA manufacturers may identify their interest and capability to respond to the requirement by email at the address listed above The email address of the negotiator assigned to this requirement is [email protected].

Bid Protests Not Available